Winnie Chan

University of Maryland, College Park — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index1.6kcitations60works0.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(15), Herpesvirus Infections and Treatments(8), Diet and metabolism studies(8), Poxvirus research and outbreaks(7), Growth Hormone and Insulin-like Growth Factors(6)

Publications60 total

Author response: Intergenerational transport of double-stranded RNA in C. elegans can limit heritable epigenetic changes
2025Open Access
Intergenerational transport of double-stranded RNA in C. elegans can limit heritable epigenetic changes
eLife·2025· 1 citedOpen Access
Author response: Intergenerational transport of double-stranded RNA in C. elegans can limit heritable epigenetic changes
2024Open Access
Intergenerational transport of double-stranded RNA in C. elegans can limit heritable epigenetic changes
2024Open Access
Intergenerational transport of double-stranded RNA in C. elegans can limit heritable epigenetic changes
eLife·2024· 2 citedOpen Access
Intergenerational transport of double-stranded RNA limits heritable epigenetic changes
2024· 1 citedOpen Access
Abstract 6225: Developing a novel combination therapy using engineered chimeric antigen receptor natural killer cells targeting avsialidase with avsialidase-armed oncolytic vaccinia virus in solid tumor models
Cancer Research·2022· 3 cited
Abstract 3300: Glycoimmune checkpoint and tumor stroma-targeted oncolytic vaccinia virus for the treatment of solid tumors
Cancer Research·2022
KDOQI clinical practice guideline for nutrition in CKD: 2020 update
Nephrology and Dialysis·2022· 6 citedOpen Access
Intergenerational transport of double-stranded RNA in <i>C. elegans</i> can limit heritable epigenetic changes
2021· 2 citedOpen Access
Abstract 6713: Oncolytic adenoviruses expressing immune modulators enhance tumor cell killing in human cancer 3D microtumor models
Cancer Research·2020· 3 cited
Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor
Molecular Therapy — Oncolytics·2016· 32 citedOpen Access
Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells
Cytotherapy·2016· 26 cited
Mo, Timothy
The Encyclopedia of Postcolonial Studies·2016
An Unusual Cause of Severe Immunosuppression
Canadian Journal of General Internal Medicine·2015· 1 citedOpen Access
Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells
Blood·2015· 34 citedOpen Access
Oncolytic Poxviruses
Annual Review of Virology·2014· 97 citedOpen Access
Myxoma Virus Protein M029 Is a Dual Function Immunomodulator that Inhibits PKR and Also Conscripts RHA/DHX9 to Promote Expanded Host Tropism and Viral Replication
PLoS Pathogens·2013· 68 citedOpen Access
Oncolytic myxoma virus: The path to clinic
Vaccine·2013· 89 cited
Myxoma and Vaccinia Viruses Bind Differentially to Human Leukocytes
Journal of Virology·2013· 27 cited
page 1 of 3Next →

Frequent Co-authors

Richard J. Krieg(9), James C.M. Chan(9), Grant McFadden(8), Brian M. Ward(5), Masmudur M. Rahman(4), Christopher R. Cogle(4), Richard B. Brandt(4), Nancy B. Kuemmerle(4), Hong Jin(3), Helen Zhou(3), George Kemble(3), Marian Wang(3), Joel D. Kopple(3), Jan S. Moreb(3), Howard Trachtman(3), Satoshi Hisano(3), Nancy Villa(3), Nathan Shugarts(3), Aishwarya Sathya(3), Andrew Yi(3)